US Proton Therapy Outlook 2017

  • September 2013
  • -
  • -
  • 65 pages

Physicians, in the face of an alarmingly rising incidences of cancer and limited treatment options are being forced to look for treatments beyond the conventional ones. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to the low number of proton therapy centers. Hence, many research institutes and hospitals are now investing in proton therapy to make it more accessible to patients.

According to the “US Proton Therapy Outlook 2017” by RNCOS, the United States will be home to almost 27 such centers by 2017, a number, which is almost double the current figure. Consequentially, the market will breach the Billion dollar mark to attain revenue of US$ 1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer demographics of US and the various possible causes for a high incidence there. The document covers the historical trend (2008-2013) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.

It describes the various types of radiation therapies, which can be used to treat cancer, as well as their disadvantages. Special attention has been given on proton therapy and its benefits that make it stand out amidst the conventional treatment options. The study dedicates a complete chapter on the various components of any proton therapy center and covers issues related to accelerators, delivery, transportation, planning and positioning systems to human resources required to setup a center.

As for the market, the report provides the state-wide distribution of proton therapy centers in USA. A thorough analysis has been done on the existing and upcoming proton therapy centers to measure the market size and its future condition. The report further provides the state-wise statistics of potential patients for proton therapy and the latter’s current market penetration. This is then followed by a section dedicated to market opportunity assessment which would help service providers and vendors to extract benefits from the largely untapped but lucrative market.

After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand and its probable transformation by 2017 for service providers and equipment vendors. There is also a ‘strengths-weakness’ analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in US till 2017 in the report, thus making it a must read for consultants and companies planning to enter the market.

Table Of Contents

1. Analyst View
2. Research Methodology
3. US Cancer Demographics
3.1 Incidence by State
3.2 Incidence by Site
4. Current Radiation Therapies
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Proton Therapy
4.6.1 Why Proton Therapy?
5. Components of a Standard Proton Therapy Center
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource
6. US Proton Therapy Market Outlook to 2017
6.1 Current Market Size and Future Growth
6.2 Potential Patients by State (2013 and 2017)
6.2.1 Market Penetration
6.3 Analysis of Existing and Forthcoming Players
6.3.1 Service Providers
6.3.2 Equipment Providers
6.4 Market Opportunity Assessment
6.5 Market Trends
6.5.1 Number of Treatment Rooms
6.5.2 Type of Proton Accelerator
7. Reimbursement Scenario
8. Industry Drivers and Restraints
8.1 Drivers
8.2 Restraints
9. Competitive Landscape and Strategic Analysis
9.1 IBA
9.2 Hitachi
9.3 Mevion Medical Systems
9.4 Varian

List of Figures:

Figure 3-1: Cancer Incidence (Million), 2008-2013
Figure 3-2: Cancer Mortality (‘000), 2008-2013
Figure 3-3: Cancer Prevalence (Million), 2008-2013
Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2013-2017
Figure 6-2: Share of Proton Therapy Market in Potential Market (2013)
Figure 6-3: Market Share of Service Providers (2013 and 2017)
Figure 6-4: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2013 and 2017)
Figure 6-5: Proton Therapy Center by Number of Treatment Rooms (2013 and 2017)
Figure 6-6: Proton Therapy Center by Type of Proton Accelerator (2013 and 2017)

List of Tables:

Table 3-1: Cancer Incidence by State (Million), 2008-2013
Table 3-2: Cancer Incidence by Site (Million), 2008-2013
Table 6-1: State wide Potential Patients for Proton Therapy (2013 and 2017)
Table 6-2: Existing Proton Therapy Centers
Table 6-3: Upcoming Proton Therapy Centers (2014 to 2017)
Table 6-4: Proton Therapy Equipment Providers with number of installations till 2013
Table 6-5: Proton Therapy Equipment Providers with Number of Installations by 2017
Table 9-1: IBA - Proton Therapy Products and Services
Table 9-2: IBA - Key Financials (Million US$), 2010-2012
Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
Table 9-4: IBA - Strengths and Weaknesses
Table 9-5: Hitachi - Key Financials (Billion US$), 2010-2012
Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
Table 9-7: Hitachi - Strengths and Weaknesses
Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
Table 9-9: Mevion - Strengths and Weaknesses
Table 9-10: Varian - Proton Therapy Products and Services
Table 9-11: Varian - Key Financials (Billion US$), 2010-2012
Table 9-12: Varian: Proton Therapy Installations
Table 9-13: Varian - Strengths and Weaknesses

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...

Inhaled Asthma Therapeutics Market

Inhaled Asthma Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment ...

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.